comparison of glp-1 agonists Treatment with Receptor GLP-1 Agonists for Weight Loss:

Aigner, T., Haag, J., Martin, J

Liraglutide attenuates diabetic cardiomyopathy via the ILK/PI3K/AKT/PTEN signaling pathway in rats with streptozotocin-induced type 2 diabetes mellitus

Furthermore, the administration of exogenous GLP-1 resulted in elevated calcitonin expression in the thyroids of normal (wild-type) mice

Tirzepatide was groundbreaking as the first dual GIP/GLP-1 receptor agonist, but it is no longer the only advanced option available

These effects not only help manage blood sugar levels in people with type 2 diabetes but also play a significant role in weight management

Furthermore, its not recommended to take multiple GLP-1 agonists without consulting a healthcare professional, as its unclear how they may interact